The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy
Open accessAbstract
Peripartum cardiomyopathy (PPCM) is an often fatal disease that affects pregnant women who are near delivery, and it occurs more frequently in women with pre-eclampsia and/or multiple gestation. The aetiology of PPCM, and why it is associated with pre-eclampsia, remain unknown. Here we show that PPCM is associated with a systemic angiogenic imbalance, accentuated by pre-eclampsia. Mice that lack cardiac PGC-1α, a powerful regulator of angiogenesis, develop profound PPCM. Importantly, the PPCM is entirely rescued by pro-angiogenic therapies. In humans, the placenta in late gestation secretes VEGF inhibitors like soluble FLT1 (sFLT1), and this is accentuated by multiple gestation and pre-eclampsia. This anti-angiogenic environment is accompanied by subclinical cardiac dysfunction, the extent of which correlates with circulating levels of sFLT1. Exogenous sFLT1 alone caused diastolic dysfunction in wild-type mice, and profound systolic dysfunction in mice lacking cardiac PGC-1α. Finally, plasma samples from women with PPCM contained abnormally high levels of sFLT1. These data indicate that PPCM is mainly a vascular disease, caused by excess anti-angiogenic signalling in the peripartum period. The data also explain how late pregnancy poses a threat to cardiac homeostasis, and why pre-eclampsia and multiple gestation are important risk factors for the development of PPCM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Self-citationA Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Self-citationHeterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Latest Advances in Understanding Preeclampsia
Redman, C. W., & Sargent, I. L. (2005) · Science · doi:10.1126/science.1111726 · Cited by 2,607
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Self-citationSoluble endoglin contributes to the pathogenesis of preeclampsia
Venkatesha, S., Toporsian, M., Lam, C., Hanai, J.-I., Mammoto, T., Kim, Y. M., Bdolah, Y., Lim, K.-H., Yuan, H.-T., Libermann, T. A., et al. (2006) · Nature Medicine · doi:10.1038/nm1429 · Cited by 1,855 · cited 1×
“Samples for real-time PCR analyses were reverse transcribed (Invitrogen), and quantitative real-time PCR reactions were performed on the cDNAs in the presence of fluorescent dye (SYBR green), on a BioRad CFX 384 Touch ™ Real-Time PCR Detection System.”
Self-citationTei, C., Ling, L. H., Hodge, D. O., Bailey, K. R., Oh, J. K., Rodeheffer, R. J., Tajik, A. J., & Seward, J. B. (1995) · PubMed · Cited by 1,547
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Handschin, C., & Spiegelman, B. M. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0037 · Cited by 1,090
HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α
Arany, Z., Foo, S.-Y., Ma, Y., Ruas, J. L., Bommi-Reddy, A., Girnun, G., Cooper, M., Laznik, D., Chinsomboon, J., Rangwala, S. M., et al. (2008) · Nature · doi:10.1038/nature06613 · Cited by 1,054 · cited 3×
“8,9 Anti-angiogenic therapies, including antibodies that neutralize VEGF and small molecule VEGF receptor inhibitors, are being increasingly used in the oncological and ophthalmological settings, and cardiomyopathy and heart failure have recently been recognized as important side effects 10,11 ,…”
BackgroundInfluentialSelf-citationA Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy
Hilfiker-Kleiner, D., Kaminski, K., Podewski, E., Bonda, T., Schaefer, A., Sliwa, K., Forster, O., Quint, A., Landmesser, U., Doerries, C., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.036 · Cited by 906
Self-citationPearson, G. D., Veille, J.-C., Rahimtoola, S., Hsia, J., Oakley, C. M., Hosenpud, J. D., Ansari, A., & Baughman, K. L. (2000) · JAMA · doi:10.1001/jama.283.9.1183 · Cited by 858
Arany, Z., He, H., Lin, J., Hoyer, K., Handschin, C., Toka, O., Ahmad, F., Matsui, T., Chin, S., Wu, P.-H., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.03.002 · Cited by 694
Self-citationCarmeliet, P., Ng, Y.-S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V., et al. (1999) · Nature Medicine · doi:10.1038/8379 · Cited by 679
Agah, R., Frenkel, P. A., French, B. A., Michael, L. H., Overbeek, P. A., & Schneider, M. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119509 · Cited by 606
Kasner, M., Westermann, D., Steendijk, P., Gaub, R., Wilkenshoff, U., Weitmann, K., Hoffmann, W., Poller, W., Schultheiss, H.-P., Pauschinger, M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.661983 · Cited by 565
PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice
Tran, M., Tam, D., Bardia, A., Bhasin, M., Rowe, G. C., Kher, A., Zsengeller, Z. K., Akhavan-Sharif, M. R., Khankin, E. V., Saintgeniez, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58662 · Cited by 499
Self-citationSliwa, K., Fett, J., & Elkayam, U. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69253-2 · Cited by 443
Fett, J. D., Christie, L. G., Carraway, R. D., & Murphy, J. G. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.12.1602 · Cited by 393
The transcriptional coactivator PGC-1α mediates exercise-induced angiogenesis in skeletal muscle
Chinsomboon, J., Ruas, J., Gupta, R. K., Thom, R., Shoag, J., Rowe, G. C., Sawada, N., Raghuram, S., & Arany, Z. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909131106 · Cited by 379
Self-citationArany, Z., Novikov, M., Chin, S., Ma, Y., Rosenzweig, A., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603615103 · Cited by 374
Self-citationGiordano, F. J., Gerber, H.-P., Williams, S.-P., VanBruggen, N., Bunting, S., Ruiz-Lozano, P., Gu, Y., Nath, A. K., Huang, Y., Hickey, R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091415198 · Cited by 370
Noori, M., Donald, A. E., Angelakopoulou, A., Hingorani, A. D., & Williams, D. J. (2010) · Circulation · doi:10.1161/circulationaha.109.895458 · Cited by 362
PGC-1 Coactivators in Cardiac Development and Disease
Rowe, G. C., Jiang, A., & Arany, Z. (2010) · Circulation Research · doi:10.1161/circresaha.110.223818 · Cited by 355
Self-citationClinical Characteristics of Peripartum Cardiomyopathy in the United States
Elkayam, U. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.047 · Cited by 352
Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia
Thadhani, R., Kisner, T., Hagmann, H., Bossung, V., Noack, S., Schaarschmidt, W., Jank, A., Kribs, A., Cornely, O. A., Kreyssig, C., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.034793 · Cited by 346
Self-citationHandschin, C., Choi, C. S., Chin, S., Kim, S., Kawamori, D., Kurpad, A. J., Neubauer, N., Hu, J., Mootha, V. K., Kim, Y.-B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31785 · Cited by 335
Improved outcomes in peripartum cardiomyopathy with contemporary
Amos, A. M., Jaber, W. A., & Russell, S. D. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.02.008 · Cited by 322
Maternal Cardiac Dysfunction and Remodeling in Women With Preeclampsia at Term
Melchiorre, K., Sutherland, G. R., Baltabaeva, A., Liberati, M., & Thilaganathan, B. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.162321 · Cited by 306
Weber, G. M., Murphy, S. N., McMurry, A. J., MacFadden, D., Nigrin, D. J., Churchill, S., & Kohane, I. S. (2009) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m3191 · Cited by 292
Tei-Index in patients with mild-to-moderate congestive heart failure
Bruch, C., Schmermund, A., Marin, D., Katz, M., Bartel, T., Schaar, J., & Erbel, R. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2246 · Cited by 284
Kuo, C. J., Farnebo, F., Yu, E. Y., Christofferson, R., Swearingen, R. A., Carter, R., von Recum, H. A., Yuan, J., Kamihara, J., Flynn, E., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081615298 · Cited by 271
Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
Bdolah, Y., Lam, C., Rajakumar, A., Shivalingappa, V., Mutter, W., Sachs, B. P., Lim, K. H., Bdolah-Abram, T., Epstein, F. H., & Karumanchi, S. A. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.10.783 · Cited by 235
Self-citationWolf, M., Hubel, C. A., Lam, C., Sampson, M., Ecker, J. L., Ness, R. B., Rajakumar, A., Daftary, A., Shakir, A. S. M., Seely, E. W., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0548 · Cited by 222
Self-citationRajakumar, A., Michael, H. M., Rajakumar, P. A., Shibata, E., Hubel, C. A., Karumanchi, S. A., Thadhani, R., Wolf, M., Harger, G., & Markovic, N. (2005) · Placenta · doi:10.1016/j.placenta.2004.09.001 · Cited by 190
Self-citationRajakumar, A., Cerdeira, A. S., Rana, S., Zsengeller, Z., Edmunds, L., Jeyabalan, A., Hubel, C. A., Stillman, I. E., Parikh, S. M., & Karumanchi, S. A. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.182170 · Cited by 180
Self-citationAetiology and risk factors of peripartum cardiomyopathy: A systematic review
Ntusi, N., & Mayosi, B. M. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.06.054 · Cited by 169
Hubel, C. A., Wallukat, G., Wolf, M. S., Herse, F., Rajakumar, A., Roberts, J. M., Markovic, N., Thadhani, R., Luft, F. C., & Dechend, R. (2007) · Hypertension · doi:10.1161/01.hyp.0000256565.20983.d4 · Cited by 148
Poulsen, S. H., Jensen, S. E., Nielsen, J. C., Møller, J. E., & Egstrup, K. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00599-8 · Cited by 148
May, D., Gilon, D., Djonov, V., Itin, A., Lazarus, A., Gordon, O. M., Rosenberger, C., & Keshet, E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707778105 · Cited by 126
Schilling, J. D., Lai, L., Sambandam, N., Dey, C. E., Leone, T. C., & Kelly, D. P. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.959833 · Cited by 125
Goland, S., Bitar, F., Modi, K. A., Safirstein, J. G., Ro, A. S., Mirocha, J., Khatri, N., & Elkayam, U. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.01.007 · Cited by 118
Saxena, A. R., Karumanchi, S. A., Brown, N. J., Royle, C. M., McElrath, T. F., & Seely, E. W. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.147595 · Cited by 116
Self-citationAngiogenic imbalance in the pathophysiology of preeclampsia: Newer insights
Bdolah, Y., Sukhatme, V. P., & Karumanchi, S. A. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.07.003 · Cited by 113
Self-citationHorne, B. D., Rasmusson, K., Alharethi, R. A., Budge, D., Brunisholz, K. D., Metz, T. D., Carlquist, J. F., Connolly, J. J., Porter, T. F., LAPPE, D. L., et al. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.959205 · Cited by 83
Reversible Cardiomyopathy Associated with Sunitinib and Sorafenib
Uraizee, I., Cheng, S. C., & Moslehi, J. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1108849 · Cited by 71
Update on Peripartum Cardiomyopathy
Cruz, M., Briller, J. E., & Hibbard, J. U. (2010) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2010.02.003 · Cited by 27
Cited by
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
Self-citationRana (2019) · doi:10.1161/circresaha.118.313276 · Cited by 2,095
ESC Guidelines on the management of cardiovascular diseases during pregnancy
Endorsed by the European Society of Gynecology (ESG), T. A. F. E. P. C. (., Authors/Task Force Members, Regitz-Zagrosek, V., Blomstrom Lundqvist, C., Borghi, C., Cifkova, R., Ferreira, R., Foidart, J.-M., Gibbs, J. S. R., Gohlke-Baerwolf, C., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr218 · Cited by 1,924
Self-citationMechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Mechanisms and regulation of endothelial VEGF receptor signalling
Simons, M., Gordon, E., & Claesson-Welsh, L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.87 · Cited by 1,498
Metadata
- Authors
- Patten, I. S., Rana, S., Shahul, S., Rowe, G. C., Jang, C., Liu, L., Hacker, M. R., Rhee, J. S., Mitchell, J., Mahmood, F., Hess, P., Farrell, C., Koulisis, N., Khankin, E. V., Burke, S. D., Tudorache, I., Bauersachs, J., Monte, F. D., Hilfiker-Kleiner, D., Karumanchi, S. A., & Arany, Z.
- Venue
- Nature
- Published
- 2012-05
- Volume
- 485
- Issue
- 7398
- Pages
- 333-338
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2100128206
- Cited by
- 572
- References
- 51
- FWCI
- 24.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.